phosphorodiamidate morpholino oligomer AVI-4126
Term · Oncology and biomedicine · MLC-T-ONC-016014
A c-Myc antisense phosphorodiamidate morpholino oligomer (PMO) with potential antineoplastic activity. Phosphorodiamidate morpholino oligomer AVI-4126 binds to c-Myc mRNA and blocks its translation, which may result in the death of tumor cells overexpressing c-Myc. Differing from traditional antisense oligodeoxynucleotides (ODNs), neutrally charged PMOs are composed of subunits of nucleic acid bases linked to a synthetic backbone and, so, are less prone to enzymatic degradation. c-Myc, a proto-oncogene overexpressed in a variety of cancers, is involved in cellular proliferation, differentiation, and apoptosis.
| Identifier | MLC-T-ONC-016014 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | PMO AVI-4126 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016014",
"term": "phosphorodiamidate morpholino oligomer AVI-4126",
"field": "Oncology and biomedicine",
"definition": "A c-Myc antisense phosphorodiamidate morpholino oligomer (PMO) with potential antineoplastic activity. Phosphorodiamidate morpholino oligomer AVI-4126 binds to c-Myc mRNA and blocks its translation, which may result in the death of tumor cells overexpressing c-Myc. Differing from traditional antisense oligodeoxynucleotides (ODNs), neutrally charged PMOs are composed of subunits of nucleic acid bases linked to a synthetic backbone and, so, are less prone to enzymatic degradation. c-Myc, a proto-oncogene overexpressed in a variety of cancers, is involved in cellular proliferation, differentiation, and apoptosis.",
"abbreviation": "PMO AVI-4126",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/phosphorodiamidate-morpholino-oligomer-avi-4126/"
}
Record 13,136 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.